Atlas Trials

Study of Single-dose DS-3201b in Participants With Hepatic Impairment

Clinical trial NCT04276662 · COMPLETED

Trial details

NCT number
NCT04276662
Sponsor
Daiichi Sankyo
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2019-11-21
Primary completion
2021-02-23
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.